Gut-Maternal/Neonatal

Shifts in the maternal microbiome and immune function occur naturally during the course of pregnancy. However these changes can negatively impact fetal immune and microbiome development. This in turn can increase the potential risk of allergic and autoimmune conditions in later life. Clinical studies have demonstrated the immune development and microbiome balancing power of OMNi-BiOTiC^® PandA with outcomes including reduced risk of infant/childhood allergic and atopic disease (i.e. eczema), reduced colic, and improved maternal gut function and comfort.